Pharmgate Animal Health specializes in the development and marketing of high quality medicines for the control of disease in livestock and poultry in North America.
We are dedicated to the marketing and support of innovative new products and differentiated generics.
Our commitment to our customers is to provide them with innovative products of a consistently high quality at an attractive price.
October 16, 2014 - Pharmgate announces agreement to acquire the assets of Pennfield Animal Health.
November 25, 2013 - Pharmgate receives regulatory approval for its chlortetracycline product, Deracin® 22% Granular, in Canada.
August 8, 2013 - Pharmgate acquires chlortetracycline product licenses in Latin America.
March 17, 2014 - Pharmgate Animal Health announces the Canadian launch of Aivlosin® 17% Tylvalosin Medicated Premix for the treatment of porcine proliferative enteritis (PPE) associated with Lawsonia intracellularis infection in swine
August 1, 2014 - Pharmgate Animal Health announces two Sales and Marketing appointments.
August 1, 2014 - ECO Animal Health and its North American marketing joint venture, Pharmgate Animal Health, announce the sponsorship of a Research Fellowship in Applied Pharmacology at the Swine Medicine Education Center of Iowa State University.
Pharmgate Animal Health LLC
161 North Franklin Turnpike
Ramsey, NJ 07446
Pharmgate Animal Health Canada, Inc.
5402 Tenth Line, R.R. #2
Erin, Ontario N0B 1T0